Form 4 for STX Seagate Technology
Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0001137789-23-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-05 | 2023-08-31+ | STX | MOSLEY WILLIAM D | CEO, Dir | S - Sale+OE | $71.17 | -298.9K | 616.3K | -33% | -$21.27M |
| DM | 2023-09-05 | 2023-08-31+ | STX | MOSLEY WILLIAM D | CEO, Dir | M - OptEx | $34.37 | +298.9K | 715.2K | +72% | +$10.27M |
| DM | 2023-09-05 | 2023-08-31+ | STX | MOSLEY WILLIAM D | CEO, Dir | M - OptEx | $0.00 | -298.9K | 153.2K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-08-31 | S | D | 5,613 | $69.34 | 710,696 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F4) These Ordinary Shares were sold in multiple trades at prices ranging from $68.70 to $69.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Ordinary Shares | 2023-08-31 | S | D | 53,990 | $70.35 | 656,706 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F5) These Ordinary Shares were sold in multiple trades at prices ranging from $69.70 to $70.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Ordinary Shares | 2023-08-31 | S | D | 40,397 | $70.81 | 616,309 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F6) These Ordinary Shares were sold in multiple trades at prices ranging from $70.70 to $70.94. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Ordinary Shares | 2023-08-31 | M | A | 100,000 | $30.95 | 716,309 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 5 | Common | Ordinary Shares | 2023-08-31 | S | D | 100,000 | $70.08 | 616,309 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F7) These Ordinary Shares were sold in multiple trades at prices ranging from $70.00 to $70.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Ordinary Shares | 2023-09-01 | S | D | 16,607 | $71.40 | 698,562 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F8) These Ordinary Shares were sold in multiple trades at prices ranging from $70.77 to $71.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Ordinary Shares | 2023-09-01 | S | D | 13,791 | $72.29 | 684,771 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F9) These Ordinary Shares were sold in multiple trades at prices ranging from $71.77 to $72.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Ordinary Shares | 2023-09-01 | S | D | 62,857 | $73.45 | 621,914 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F10) These Ordinary Shares were sold in multiple trades at prices ranging from $72.80 to $73.79. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Ordinary Shares | 2023-09-01 | S | D | 5,605 | $74.01 | 616,309 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F11) These Ordinary Shares were sold in multiple trades at prices ranging from $73.81 to $74.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Ordinary Shares | 2023-08-31 | M | A | 100,000 | $36.09 | 716,309 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F3) This number reflects the deduction of two shares due to an accounting error. (F2) Includes 314 Ordinary Shares purchased by Reporting Person on January 31, 2023 under the Issuer's Employee Stock Purchase Plan. Such acquisition is exempt from reporting pursuant to Rule 16b-3 under theSecurities Exchange Act of 1934. |
| 11 | Common | Ordinary Shares | 2023-09-01 | M | A | 98,860 | $36.09 | 715,169 | D | — | — | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 12 | Derivative | NQ Options | 2023-08-31 | M | D | 100,000 | $0.00 | 98,860 | D | $36.09 · 2017-09-09 to 2023-09-09 | 100,000 Ordinary Shares | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F12) Options granted to the Reporting Person under the Issuer's 2012 Equity Incentive Plan are subject to a four-year vesting schedule. One quarter of the options vested on September 11, 2018, the remaining options vested in equal monthly installments over the 36 months following September 11, 2018. |
| 13 | Derivative | NQ Options | 2023-09-01 | M | D | 98,860 | $0.00 | 0 | D | $36.09 · 2017-09-09 to 2023-09-09 | 98,860 Ordinary Shares | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F12) Options granted to the Reporting Person under the Issuer's 2012 Equity Incentive Plan are subject to a four-year vesting schedule. One quarter of the options vested on September 11, 2018, the remaining options vested in equal monthly installments over the 36 months following September 11, 2018. |
| 14 | Derivative | NQ Options | 2023-08-31 | M | D | 100,000 | $0.00 | 153,188 | D | $30.95 · 2018-09-11 to 2024-09-11 | 100,000 Ordinary Shares | (F1) The option exercises and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F13) Options granted to the Reporting Person under the Issuer's 2012 Equity Incentive Plan are subject to a four-year vesting schedule. One quarter of the options vested on September 9, 2017, the remaining options vested in equal monthly installments over the 36 months following September 9, 2017. |